The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein
Open accessAbstract
A physical and functional interaction between the Ca(2+)-binding protein Mts1 (S100A4) and the tumor suppressor p53 protein is shown here for the first time. We demonstrate that Mts1 binds to the extreme end of the C-terminal regulatory domain of p53 by several in vitro and in vivo approaches: co-immunoprecipitation, affinity chromatography, and far Western blot analysis. The Mts1 protein in vitro inhibits phosphorylation of the full-length p53 and its C-terminal peptide by protein kinase C but not by casein kinase II. The Mts1 binding to p53 interferes with the DNA binding activity of p53 in vitro and reporter gene transactivation in vivo, and this has a regulatory function. A differential modulation of the p53 target gene (p21/WAF, bax, thrombospondin-1, and mdm-2) transcription was observed upon Mts1 induction in tet-inducible cell lines expressing wild type p53. Mts1 cooperates with wild type p53 in apoptosis induction. Our data imply that the ability of Mts1 to enhance p53-dependent apoptosis might accelerate the loss of wild type p53 function in tumors. In this way, Mts1 can contribute to the development of a more aggressive phenotype during tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
p53 mutations in colorectal cancer.
Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,003
Oncogenic forms of p53 inhibit p53-regulated gene expression
Kern, S., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
Isaacs, W. B., Carter, B. S., & Ewing, C. M. (1991) · PubMed · Cited by 433
Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Weber, D. J., Rust, R. R., & Baldisseri, D. M. (2000) · Nature Structural Biology · doi:10.1038/76797 · Cited by 352
Selivanova, G., Iotsova, V., Okan, I., Fritsche, M., Ström, M., Groner, B., Grafström, R. C., & Wiman, K. G. (1997) · Nature Medicine · doi:10.1038/nm0697-632 · Cited by 343
Self-citationPrognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., Renshaw, C., West, C. R., Winstanley, J. H., Robertson, L. B., & Barraclough, R. (2000) · PubMed · Cited by 305
Ebralidze, A., Tulchinsky, E., Grigorian, M., Afanasyeva, A., Senin, V, Revazova, E., & Lukanidin, E. (1989) · Genes & Development · doi:10.1101/gad.3.7.1086 · Cited by 301
Self-citationInactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member
Wadhwa, R., Takano, S., Robert, M., Yoshida, A., Nomura, H., Reddel, R. R., Mitsui, Y., & Kaul, S. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29586 · Cited by 223
Frazier, M. W., He, X., Wang, J., Gu, Z., Cleveland, J. L., & Zambetti, G. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3735 · Cited by 194
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Casey, G., LO-HSUEH, M., Lopez, M. E., Vogelstein, B., & Stanbridge, E. J. (1991) · PubMed · Cited by 189
Kustikova, O., Kramerov, D., Grigorian, M., Berezin, V., Bock, E., Lukanidin, E., & Tulchinsky, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7095 · Cited by 187
Self-citationElstner, E., Linker-Israeli, M., SAID, J. W., Umiel, T., Vos, S. D., Shintaku, I. P., Heber, D., Binderup, L., Uskoković, M. R., & Koeffler, H. P. (1995) · PubMed · Cited by 183
Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
Felix, C. A., Kappel, C. C., Mitsudomi, T., Nau, M. M., Tsokos, M., Crouch, G. D., Nisen, P. D., Winick, N. J., & Helman, L. J. (1992) · PubMed · Cited by 180
O'Connell, K. A., & Edidin, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.521 · Cited by 177
Kriajevska, M. V., Cardenas, M. N., Grigorian, M. S., Ambartsumian, N. S., Georgiev, G. P., & Lukanidin, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32072-0 · Cited by 171
Self-citationBinding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin
Takenaga, K., Nakamura, Y., Sakiyama, S., Hasegawa, Y., Sato, K., & Endo, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.5.757 · Cited by 157
Covalent and noncovalent modifiers of the p53 protein
Jayaraman, L., & Prives, C. L. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050271 · Cited by 150
Kriajevska, M. V., Tarabykina, S., Bronstein, I. B., Maitland, N. J., Lomonosov, M., Hansen, K. H., Georgiev, G. P., & Lukanidin, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9852 · Cited by 129
Self-citationRegulation of the Cryptic Sequence-specific DNA-binding Function of p53 by Protein Kinases
Hupp, T. R., & Lane, D. P. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.024 · Cited by 124
Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells
Sengupta, S., Vonesch, J., Waltzinger, C., Zheng, H., & Wasylyk, B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6051 · Cited by 121
Gartel, A. L., Serfas, M. S., Gartel, M., Goufman, E., Wu, G. S., El‐Deiry, W. S., & Tyner, A. L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0264 · Cited by 120
Katayose, D., Gudas, J. M., Nguyen, H., Srivastava, S., Cowan, K. H., & Seth, P. K. (1995) · PubMed · Cited by 116
Analysis of the p53 gene in human uterine carcinoma cell lines.
Yaginuma, Y., & Westphal, H. (1991) · PubMed · Cited by 106
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A., & Venanzi, F. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l · Cited by 105
Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
Romano, J., Ehrhart, J., Duthu, A., Kim, C. M., Appella, E., & May, P. (1989) · PubMed · Cited by 96
Lányi, Á., Deb, D., Seymour, R. C., Ludes-Meyers, J. H., Subler, M. A., & Deb, S. (1998) · Oncogene · doi:10.1038/sj.onc.1201857 · Cited by 87
Watanabe, Y., Usada, N., Minami, H., Morita, T., Tsugane, S., Ishikawa, R., Kohama, K., Tomida, Y., & Hidaka, H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81530-d · Cited by 86
The single-stranded DNA end binding site of p53 coincides with the C- terminal regulatory region
Selivanova, G., Iotsova, V., Kiseleva, E., Ström, M., Bakalkin, G., Grafström, R. C., & Wiman, K. G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.18.3560 · Cited by 74
Self-citationScotto, C., Delphin, C., Deloulme, J., & Baudier, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7168 · Cited by 72
Regulation of p53 protein function through alterations in protein-folding pathways
Hupp, T. R. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050272 · Cited by 66
Yang, X., Pater, A., & Tang, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202843 · Cited by 51
Induction of 18A2/mts1 Gene Expression and Its Effects on Metastasis and Cell Cycle Control
Parker, C., WHITTAKER, P. A., Usmani, B. A., Lakshmi, M. S., & Sherbet, G. V. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.1021 · Cited by 48
Mundt, M., Hupp, T. R., Fritsche, M., Merkle, C., Hansen, S., Lane, D. P., & Groner, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201174 · Cited by 46
Cheng, Y., Li, Y., Wu, J. D., Long, S., Tzai, T., Tzeng, C., & Lai, M. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130307 · Cited by 40
Wang, H., Mohammad, R. M., Werdell, J., & Shekhar, M. P. V. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.6.915 · Cited by 35
The properties of p53 proteins selected for the loss of suppression of transformation.
Olson, D., & Levine, A. J. (1994) · PubMed · Cited by 23
Lukanidin, E. M., & Georgiev, G. P. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61109-4_8 · Cited by 22
Self-citation
Cited by
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Intracellular and extracellular roles of S100 proteins
Donato, R. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10296 · Cited by 974
Marenholz, I., Heizmann, C. W., & Fritz, G. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.096 · Cited by 848
Calcium-dependent and -independent interactions of the S100 protein family
Santamaria-Kisiel, L., Rintala-Dempsey, A. C., & Shaw, G. S. (2006) · Biochemical Journal · doi:10.1042/bj20060195 · Cited by 581
A review of the S100 proteins in cancer
Salama, I., Malone, P. S., Mihaimeed, F., & Jones, J. L. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.04.009 · Cited by 442
Metadata
- Authors
- Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G., & Lukanidin, E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 276
- Issue
- 25
- Pages
- 22699-22708
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2149809213
- Cited by
- 282
- References
- 44
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.